Liberation Bioindustries Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$112M
- Investors
-
9
Liberation Bioindustries General Information
Description
Developer of an industrial biotechnology system designed to address the growing fermentation capacity gap in cellular agriculture. The company engages in infrastructure that commercializes novel protein manufacturing at the scale and cost structure required by the market, enabling biology innovators to achieve price parity with animal protein and customers to access healthy foods.
Contact Information
Website
liberation.bioCorporate Office
- 80 Broad Street
- 5th Floor PMB Suite 6450
- New York, NY 10004
- United States
Corporate Office
- 80 Broad Street
- 5th Floor PMB Suite 6450
- New York, NY 10004
- United States
Liberation Bioindustries Timeline
Liberation Bioindustries Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 09-Dec-2025 | $112M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 30-Jan-2025 | Cancelled | Generating Revenue | |||
| 1. Seed Round | 31-Dec-2022 | $20M | $20M | Completed | Generating Revenue |
Liberation Bioindustries Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed | 6,097,563 | $0.000100 | $4 | $4 | 1x | $4 | 9.69% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Liberation Bioindustries Signals
Liberation Bioindustries Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Echo Investment Capital | PE/Buyout | |||
| Galloways Accounting | PE-Backed Company | |||
| Thia Ventures | Venture Capital | Minority | ||
| Agronomics | Venture Capital | Minority | ||
| CPT Capital | Venture Capital | Minority |
Liberation Bioindustries Investments (1)
Liberation Bioindustries’s most recent deal was a Corporate Asset Purchase with Liberation Bioindustries (Biomanufacturing Facility in Richmond, Indiana). The deal was made on 24-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Liberation Bioindustries (Biomanufacturing Facility in Richmond, Indiana) | 24-Jan-2023 | Corporate Asset Purchase | Buildings and Property |
Liberation Bioindustries FAQs
-
When was Liberation Bioindustries founded?
Liberation Bioindustries was founded in 2022.
-
Where is Liberation Bioindustries headquartered?
Liberation Bioindustries is headquartered in New York, NY.
-
What is the size of Liberation Bioindustries?
Liberation Bioindustries has 20 total employees.
-
What industry is Liberation Bioindustries in?
Liberation Bioindustries’s primary industry is Specialty Chemicals.
-
Is Liberation Bioindustries a private or public company?
Liberation Bioindustries is a Private company.
-
What is the current valuation of Liberation Bioindustries?
The current valuation of Liberation Bioindustries is .
-
What is Liberation Bioindustries’s current revenue?
The current revenue for Liberation Bioindustries is .
-
How much funding has Liberation Bioindustries raised over time?
Liberation Bioindustries has raised $132M.
-
Who are Liberation Bioindustries’s investors?
Echo Investment Capital, Galloways Accounting, Thia Ventures, Agronomics, and CPT Capital are 5 of 9 investors who have invested in Liberation Bioindustries.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process